Induction Therapy Clinical Trials in Xiamen, Fujian
2 recruitingXiamen, Fujian, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
ImmunotherapyInduction TherapyLocally Advanced Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT07085234
Recruiting
Phase 2
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
ChemotherapyPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University208 enrolled3 locationsNCT06811844